This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a University of Toronto directory, so their publications, courses and email address may be missing. Find their university profile.
Research
Latest funding
- $906,526
A Novel SUMO2 Biologic Therapeutic for Synucleinopathies
CIHR · 2025 · Principal investigator
A Novel SUMO2 Biologic Therapeutic for Synucleinopathies
Principal investigators: Tandon, Anurag; Fraser, Paul E; Lambe, Evelyn K; Lévesque, Martin
Keywords: Animal Model; Biologic; Electrophysiology; Neurodegeneration; Protein Aggregation; Proteinopathy; Sumo; Synaptic Dysfunction; Synucleinopathy; Therapeutic
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.